Costs and benefits of early response in the Ebola virus disease outbreak in Sierra Leone

por Kellerborg, Klas, Brouwer, Werner, van Baal, Pieter
Publicado 2020

Costs and benefits of interventions aimed at major infectious disease threats: lessons from the literature

por Kellerborg, Klas, Brouwer, Werner, van Baal, Pieter
Publicado 2020

Quality-Adjusted Life-Years Lost Due to COVID-19 Mortality: Methods and Application for The Netherlands

por Wouterse, Bram, Ram, Frederique, van Baal, Pieter
Publicado 2022

Health care input constraints and cost effectiveness analysis decision rules

por van Baal, Pieter, Morton, Alec, Severens, Johan L.
Publicado 2018

The Value of Health in a Cost-Effectiveness Analysis: Theory Versus Practice

por Wouterse, Bram, van Baal, Pieter, Versteegh, Matthijs, Brouwer, Werner
Publicado 2023

The economics of improving global infectious disease surveillance

por de Vries, Linda, Koopmans, Marion, Morton, Alec, van Baal, Pieter
Publicado 2021

The Relevance of Including Future Healthcare Costs in Cost-Effectiveness Threshold Calculations for the UK NHS

por Perry-Duxbury, Megan, Lomas, James, Asaria, Miqdad, van Baal, Pieter
Publicado 2021

Decomposing cross-country differences in quality adjusted life expectancy: the impact of value sets

por Heijink, Richard, van Baal, Pieter, Oppe, Mark, Koolman, Xander, Westert, Gert
Publicado 2011

Distributional consequences of including survivor costs in economic evaluations

por Kellerborg, Klas, Brouwer, Werner, Versteegh, Matthijs, Wouterse, Bram, van Baal, Pieter
Publicado 2021

Future medical and non-medical costs and their impact on the cost-effectiveness of life-prolonging interventions: a comparison of five European countries

por Mokri, Hamraz, Kvamme, Ingelin, de Vries, Linda, Versteegh, Matthijs, van Baal, Pieter
Publicado 2022

Informal Care Costs According to Age and Proximity to Death to Support Cost-Effectiveness Analyses

por de Groot, Saskia, Santi, Irene, Bakx, Pieter, Wouterse, Bram, van Baal, Pieter
Publicado 2023

Optimizing cardiovascular disease risk screening in a low-resource setting: cost-effectiveness of program modifications in Sri Lanka modelled with nationally representative survey...

por Wijemunige, Nilmini, Rannan-Eliya, Ravindra P., van Baal, Pieter, O’Donnell, Owen
Publicado 2023

Dynamic effects of smoking cessation on disease incidence, mortality and quality of life: The role of time since cessation

por Hoogenveen, Rudolf T, van Baal, Pieter HM, Boshuizen, Hendriek C, Feenstra, Talitha L
Publicado 2008

Disease Prevention: Saving Lives or Reducing Health Care Costs?

por Grootjans-van Kampen, Inge, Engelfriet, Peter M., van Baal, Pieter H. M.
Publicado 2014

Estimating health-adjusted life expectancy conditional on risk factors: results for smoking and obesity

por van Baal, Pieter HM, Hoogenveen, Rudolf T, de Wit, G Ardine, Boshuizen, Hendriek C
Publicado 2006

Cost-Effectiveness of an Opportunistic Screening Programme and Brief Intervention for Excessive Alcohol Use in Primary Care

por Tariq, Luqman, van den Berg, Matthijs, Hoogenveen, Rudolf T., van Baal, Pieter H. M.
Publicado 2009

Cost-Effectiveness of Opportunistic Screening and Minimal Contact Psychotherapy to Prevent Depression in Primary Care Patients

por van den Berg, Matthijs, Smit, Filip, Vos, Theo, van Baal, Pieter H. M.
Publicado 2011

Future Costs in Cost-Effectiveness Analyses: Past, Present, Future

por de Vries, Linda M., van Baal, Pieter H. M., Brouwer, Werner B. F.
Publicado 2018

Improving maternal and child health in Pakistan: a programme evaluation using a difference in difference analysis

por Malik, Muhammad Ashar, Rohm, Lara Riedige, van Baal, Pieter, van Doorslaer, Eddy van Doorslaer
Publicado 2021

Disability weights for comorbidity and their influence on Health-adjusted Life Expectancy

por van Baal, Pieter HM, Hoeymans, Nancy, Hoogenveen, Rudolf T, de Wit, G Ardine, Westert, Gert P
Publicado 2006